SHANGHAI and SAN DIEGO , Nov. 7, 2024 /PRNewswire/ -- WuXi XDC Cayman Inc. ("WuXi XDC" or the "Company", stock code: 2268.
HK), a leading global CRDMO (Contract Research, Development, and Manufacturing Organization) specializing in antibody-drug conjugates (ADCs) and other bioconjugates (XDCs), is proud to announce that it has been named the winner of the "Best CDMO" at the World ADC Awards 2024 for the second consecutive year. Over the past three years, WuXi XDC has consistently earned recognition at the World ADC Awards, including being named the winner of the"Best CDMO" in 2023 and "Best CMO Runner-up" in 2022. This year, the company is also shortlisted for "Best ADC Platform Technology" and "Best CRO", highlighting its strong R&D capability and contributions to ADC development.
The prestigious award, presented at the World ADC San Diego conference, recognizes WuXi XDC's end-to-end, one-stop CRDMO excellence and exceptional services to global clients. The company's record of consecutive awards highlights its expertise and technical strength in driving innovation in the global ADC industry and meeting the complex needs from clients worldwide. The World ADC Awards are held annually to recognize the outstanding achievements by teams, projects, technologies and individuals in the global ADC industry.
The World ADC is a flagship event that brings together the brightest minds in ADC development, featuring key industry experts, breakthrough technologies, and forward-thinking colla.
